Biogen (BIIB) News Today $146.47 -0.92 (-0.62%) (As of 12/20/2024 05:45 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Biogen (NASDAQ:BIIB) Upgraded by StockNews.com to Strong-Buy RatingStockNews.com upgraded Biogen from a "buy" rating to a "strong-buy" rating in a report on Friday.December 20 at 11:23 PM | marketbeat.comBiogen’s Challenges and Cautious Outlook: Hold Rating Amid Revenue Growth Struggles and Neurology Market HurdlesDecember 20 at 9:06 PM | markets.businessinsider.comBMO Capital Downgrades Biogen (BIIB)December 20 at 4:06 PM | msn.comBiogen in talks to move to MIT's Volpe development, sources sayDecember 20 at 11:04 AM | bizjournals.comBMO cuts rating on Merck and Biogen, on lack of near term catalystDecember 20 at 11:04 AM | msn.comBiogen (NASDAQ:BIIB) Downgraded to Market Perform Rating by BMO Capital MarketsBMO Capital Markets cut shares of Biogen from an "outperform" rating to a "market perform" rating and lowered their price target for the company from $230.00 to $164.00 in a report on Friday.December 20 at 7:31 AM | marketbeat.comBiogen (NASDAQ:BIIB) Sets New 52-Week Low - Here's WhyBiogen (NASDAQ:BIIB) Sets New 1-Year Low - Here's What HappenedDecember 19 at 5:56 AM | marketbeat.comEli Lilly Alzheimer's therapy approved in ChinaDecember 18 at 5:48 PM | seekingalpha.comStifel Nicolaus Downgrades Biogen (NASDAQ:BIIB) to HoldDecember 18 at 1:55 AM | americanbankingnews.comFranklin Resources Inc. Has $71.79 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)Franklin Resources Inc. cut its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 3.5% in the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 374,747 shares of the biotechnology company's stock after selling 13,723 shares during the period. FrankliDecember 17, 2024 | marketbeat.comStifel downgrades Biogen on slow Alzheimer’s drug launch, uncertainty aheadDecember 17, 2024 | msn.comBiogen (NASDAQ:BIIB) Cut to "Hold" at Stifel NicolausStifel Nicolaus cut shares of Biogen from a "buy" rating to a "hold" rating and set a $175.00 target price on the stock. in a report on Monday.December 16, 2024 | marketbeat.comBiogen downgraded to Hold from Buy at StifelDecember 16, 2024 | tipranks.comWorld Investment Advisors LLC Acquires Shares of 5,766 Biogen Inc. (NASDAQ:BIIB)World Investment Advisors LLC bought a new stake in Biogen Inc. (NASDAQ:BIIB - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 5,766 shares of the biotechnology company's stock, valuedDecember 16, 2024 | marketbeat.comQuantinno Capital Management LP Has $595,000 Stake in Biogen Inc. (NASDAQ:BIIB)Quantinno Capital Management LP lowered its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 62.8% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 3,069 shares of the biotechnology company's stock after selling 5,172December 15, 2024 | marketbeat.comOddo BHF Asset Management Sas Buys Shares of 7,136 Biogen Inc. (NASDAQ:BIIB)Oddo BHF Asset Management Sas purchased a new position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 7,136 shares of the biDecember 14, 2024 | marketbeat.comToronto Dominion Bank Sells 22,878 Shares of Biogen Inc. (NASDAQ:BIIB)Toronto Dominion Bank cut its holdings in Biogen Inc. (NASDAQ:BIIB - Free Report) by 27.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 60,370 shares of the biotechnology company's stock after selling 22,878 sharesDecember 14, 2024 | marketbeat.comBiogen (NASDAQ:BIIB) Hits New 12-Month Low - Should You Sell?Biogen (NASDAQ:BIIB) Reaches New 12-Month Low - What's Next?December 13, 2024 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Bought by Inspire Trust Co. N.A.Inspire Trust Co. N.A. grew its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 58.5% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 10,900 shares of the biotechnology company's stock after buying an additional 4,0December 13, 2024 | marketbeat.comBiogen (NASDAQ:BIIB) Cut to Buy at StockNews.comDecember 13, 2024 | americanbankingnews.comBiogen ALS drug needs to be covered by MA plans, CMS saysDecember 12, 2024 | seekingalpha.comBiogen ALS drug needs to be covered by MA plans, CMS saysDecember 12, 2024 | msn.comIs Biogen Inc.'s (NASDAQ:BIIB) Stock Price Struggling As A Result Of Its Mixed Financials?December 12, 2024 | uk.finance.yahoo.comPrivate Medicare plans must cover Biogen's ALS drug, US agency saysDecember 12, 2024 | reuters.comSaratoga Research & Investment Management Sells 7,071 Shares of Biogen Inc. (NASDAQ:BIIB)Saratoga Research & Investment Management lessened its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 4.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 150,720 shares ofDecember 12, 2024 | marketbeat.comVirtu Financial LLC Invests $4.11 Million in Biogen Inc. (NASDAQ:BIIB)Virtu Financial LLC purchased a new position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 21,207 shares of the biotechnology company's stock, valued at approximately $4,December 12, 2024 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Acquired by Geode Capital Management LLCGeode Capital Management LLC lifted its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 1.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 3,613,020 shares of the biotechnology company's sDecember 12, 2024 | marketbeat.comPublic Employees Retirement System of Ohio Has $10.26 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)Public Employees Retirement System of Ohio cut its stake in Biogen Inc. (NASDAQ:BIIB - Free Report) by 10.9% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 52,917 shares of the biotechnology comDecember 12, 2024 | marketbeat.comNomura Asset Management Co. Ltd. Has $9.56 Million Stock Position in Biogen Inc. (NASDAQ:BIIB)Nomura Asset Management Co. Ltd. cut its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 12.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 49,303 shares of the biotechnology company's stock after selling 6December 12, 2024 | marketbeat.comBofA restarts coverage of 11 large-cap biopharmasDecember 11, 2024 | seekingalpha.comBiogen reinstated with a Neutral at BofADecember 11, 2024 | finance.yahoo.comY Intercept Hong Kong Ltd Grows Position in Biogen Inc. (NASDAQ:BIIB)Y Intercept Hong Kong Ltd raised its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 144.1% during the third quarter, according to its most recent filing with the SEC. The firm owned 7,178 shares of the biotechnology company's stock after purchasing an additional 4,238 shares durinDecember 11, 2024 | marketbeat.comEP Wealth Advisors LLC Purchases Shares of 4,090 Biogen Inc. (NASDAQ:BIIB)EP Wealth Advisors LLC acquired a new position in Biogen Inc. (NASDAQ:BIIB - Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund acquired 4,090 shares of the biotechnology company's stock, valued at approximately $793,000. A number of oDecember 11, 2024 | marketbeat.comBank of America Reiterates "Neutral" Rating for Biogen (NASDAQ:BIIB)December 11, 2024 | americanbankingnews.comBiogen (NASDAQ:BIIB) Rating Lowered to "Hold" at Jefferies Financial GroupDecember 11, 2024 | americanbankingnews.comBank of America Reaffirms "Neutral" Rating for Biogen (NASDAQ:BIIB)Bank of America restated a "neutral" rating and issued a $178.00 price target on shares of Biogen in a research report on Tuesday.December 10, 2024 | marketbeat.comAssessing Biogen: Insights From 19 Financial AnalystsDecember 9, 2024 | benzinga.comBiogen’s Modest Growth Prospects and Revenue Challenges Highlighted in Hold RatingDecember 9, 2024 | markets.businessinsider.comBiogen cut at Jefferies as '2025 has a tough setup'December 9, 2024 | msn.comBiogen downgraded to hold by Jefferies, Ocrevus royalties citedDecember 9, 2024 | msn.comBiogen (NASDAQ:BIIB) Lowered to Hold Rating by Jefferies Financial GroupJefferies Financial Group lowered Biogen from a "buy" rating to a "hold" rating and lowered their price objective for the company from $250.00 to $180.00 in a report on Monday.December 9, 2024 | marketbeat.comXTX Topco Ltd Takes Position in Biogen Inc. (NASDAQ:BIIB)XTX Topco Ltd bought a new position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 6,955 shares of the biotechnology company's stock, valued at approximately $1,348,000. ADecember 9, 2024 | marketbeat.comNational Bank of Canada FI Has $37.11 Million Stock Holdings in Biogen Inc. (NASDAQ:BIIB)National Bank of Canada FI grew its stake in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 252.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 191,465 shares of the biotechnology company's stock after purchasDecember 9, 2024 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by Royal London Asset Management Ltd.Royal London Asset Management Ltd. lowered its position in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 5.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 65,629 shares of the biotechnology company's stock after selling 3,December 8, 2024 | marketbeat.comTwo Sigma Advisers LP Purchases 235,100 Shares of Biogen Inc. (NASDAQ:BIIB)Two Sigma Advisers LP raised its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 122.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 427,600 shares of the biotechnology company's stock after purchasinDecember 6, 2024 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) Shares Sold by Fmr LLCFmr LLC decreased its position in Biogen Inc. (NASDAQ:BIIB - Free Report) by 37.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 381,214 shares of the biotechnology company's stock after selling 229,202 shares duriDecember 6, 2024 | marketbeat.com'Laggard' stocks with expanding FCF margins and attractive FCF yields – GoldmanDecember 5, 2024 | seekingalpha.comEisai And Biogen : Mexico Approves LEQEMBI For Early Alzheimer's Disease TreatmentDecember 5, 2024 | markets.businessinsider.comSarissa Capital Management LP Has $5.22 Million Stake in Biogen Inc. (NASDAQ:BIIB)Sarissa Capital Management LP trimmed its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 95.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 26,950 shares of the biotechnology company's stock after selling 616,05December 5, 2024 | marketbeat.comBiogen Inc. (NASDAQ:BIIB) is RA Capital Management L.P.'s 10th Largest PositionRA Capital Management L.P. grew its holdings in shares of Biogen Inc. (NASDAQ:BIIB - Free Report) by 20.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,184,456 shares of the biotechnology company's stock aDecember 5, 2024 | marketbeat.com Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Combine the QQQ, IWM and SPY in one trade (Ad)If you’ve been investing in the major indexes for the last 20 years, you may need a new strategy. Because the Dow Jones has returned just 349%... The Russell 2000 has returned just 397%... And the S&P 500 has returned just 450%. And although I can’t guarantee results or against losses… I want to tell you about my “2-Click Trade” that has encapsulated more than the return of ALL THREE OF THOSE INDEXES COMBINED… Plus, it targets multiple overnight payouts in a month with 84.3% accuracy! While I cannot promise future returns or against losses… You can find out about this “2-Click Trade” here. BIIB Media Mentions By Week BIIB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIIB News Sentiment▼0.120.60▲Average Medical News Sentiment BIIB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIIB Articles This Week▼1720▲BIIB Articles Average Week Get Biogen News Delivered to You Automatically Sign up to receive the latest news and ratings for BIIB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Regeneron Pharmaceuticals News Today Alnylam Pharmaceuticals News Today United Therapeutics News Today Incyte News Today Neurocrine Biosciences News Today BioMarin Pharmaceutical News Today Exact Sciences News Today Exelixis News Today Repligen News Today Madrigal Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BIIB) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biogen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BIIB Stock Alerts